Earlier, more personalized follow-up care through prostate-specific antigen (PSA) monitoring, supported by AI powered by Mayo Clinic Platform
January 09, 2026
January 09, 2026
ROCHESTER, Minnesota, Jan. 9 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Earlier, more personalized follow-up care through prostate-specific antigen (PSA) monitoring, supported by AI powered by Mayo Clinic Platform
*
ROCHESTER, Minn. To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's . . .
* * *
Earlier, more personalized follow-up care through prostate-specific antigen (PSA) monitoring, supported by AI powered by Mayo Clinic Platform
*
ROCHESTER, Minn. To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic's . . .